Company Performance: Earnings reports, revenue growth, and profitability all strongly influence investor sentiment.

Industry Trends: Overall health and outlook of the pharmaceutical industry impact stock valuation.

Regulatory Changes: Government regulations regarding drug pricing, approval processes, and healthcare policies affect potential profits.

Market Sentiment: Broad market trends (bull or bear market) and investor confidence can drive price fluctuations.

Competition: The presence and strength of competing pharmaceutical companies influence market share and pricing power.

Economic Conditions: Macroeconomic factors like interest rates, inflation, and economic growth can affect investor decisions.

Currency Exchange Rates: Fluctuations in the Korean Won (KRW) against other currencies impact earnings from international sales.

Dividend Policy: Dividend payouts and announcements attract investors seeking income, influencing demand and price.

Research & Development: Success in developing new drugs and therapies can positively impact future earnings and stock value.

Global Health Crises: Events like pandemics can create increased demand for specific pharmaceuticals, affecting stock prices.

Geopolitical Events: International political situations and trade relations can impact the supply chain and market access.

Investor Sentiment: News, rumors, and analyst ratings affect how investors view the stock.

Interest Rates: Higher rates can make borrowing more expensive, potentially slowing growth.

Inflation: Rising inflation can erode profits and make the stock less attractive.